跳至主要内容
临床试验/IRCT20150819023685N3
IRCT20150819023685N3招募中2 期

Evaluation of the effect of feneel_terminalia chebula (FT®)powder on clinical and paraclinical symptoms in patients with Covid 19.

Ghoum University of Medical Sciences0 个研究点目标入组 70 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
招募中
发起方
入组人数
70

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 65 years(—)
性别
All

入选标准

  • Inpatients diagnosed with Covid 19.
  • Patients with Covid 19 who wish to participate in the study
  • No serious heart disease, liver, kidney, blood pressure above 160 mm Hg
  • Patients who do not receive insulin
  • Non-pregnancy in women.
  • A maximum of 72 hours have passed since the beginning of the patient's hospitalization.

排除标准

  • 1. Dissatisfaction with continuing treatment.
  • 2. Need to receive medical services in the intensive care unit.

研究者

发起方
Ghoum University of Medical Sciences

相似试验